{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T07:28:24Z","timestamp":1761290904577,"version":"3.35.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1016\/j.clinthera.2008.05.005","type":"journal-article","created":{"date-parts":[[2008,6,14]],"date-time":"2008-06-14T08:54:58Z","timestamp":1213433698000},"page":"825-833","source":"Crossref","is-referenced-by-count":30,"title":["Ambrisentan for the management of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"30","author":[{"given":"Judy W.M.","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.05.005_bib1","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1161\/01.CIR.0000132476.87231.6F","article-title":"Pulmonary arterial hypertension: Future directions: Report of a National Heart, Lung, and Blood Institute\/Office of Rare Diseases workshop","volume":"109","author":"Newman","year":"2004","journal-title":"Circulation"},{"issue":"Suppl S","key":"10.1016\/j.clinthera.2008.05.005_bib2","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/j.jacc.2004.02.037","article-title":"Clinical classification of pulmonary hypertension","volume":"43","author":"Simonneau","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.05.005_bib3","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1161\/CIRCULATIONAHA.104.503540","article-title":"Pulmonary arterial hypertension","volume":"114","author":"McLaughlin","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.05.005_bib4","doi-asserted-by":"crossref","first-page":"196B","DOI":"10.1016\/0002-9149(85)90631-9","article-title":"Therapeutic application of calcium-channel antagonists for pulmonary hypertension","volume":"55","author":"Packer","year":"1985","journal-title":"Am J Cardiol."},{"unstructured":"Letairis (ambrisentan) tablets for oral use. Full prescribing information.","key":"10.1016\/j.clinthera.2008.05.005_bib5_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.005_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1056\/NEJM199508103330607","article-title":"Endothelins","volume":"333","author":"Levin","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.005_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3565(24)38132-7","article-title":"Human endothelin-1 clearance kinetics revealed by a radiotracer technique","volume":"289","author":"Parker","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.clinthera.2008.05.005_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2008.05.005_bib10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/clc.4960231128","article-title":"Bosentan and the endothelin system in congestive heart failure","volume":"23","author":"Ellahham","year":"2000","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.clinthera.2008.05.005_bib11","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/01.CIR.93.11.2068","article-title":"Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist","volume":"93","author":"Kaddoura","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2008.05.005_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/01.HYP.36.2.282","article-title":"Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage","volume":"36","author":"Muller","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2008.05.005_bib13","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2008.05.005_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/0735-1097(95)00399-1","article-title":"Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels","volume":"26","author":"Nootens","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2008.05.005_bib15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/hc0902.105719","article-title":"Selective upregulation of endothelin B receptor gene expression in severe pulmonary hypertension","volume":"105","author":"Bauer","year":"2002","journal-title":"Circulation"},{"issue":"Suppl 48","key":"10.1016\/j.clinthera.2008.05.005_bib16","doi-asserted-by":"crossref","first-page":"408S","DOI":"10.1042\/CS103S408S","article-title":"Effect of the novel endothelin(A) receptor antagonist LU 208075 on contraction and relaxation of isolated rat basilar artery","volume":"103","author":"Vatter","year":"2002","journal-title":"Clin Sci (Lond)."},{"unstructured":"Tracleer (bosentan tablets) 62.5 and 125 mg film-coated tablets.","key":"10.1016\/j.clinthera.2008.05.005_bib17_1"},{"unstructured":"Center for Drug Evaluation and Research. Application number 22-081. Pharmacology review.","key":"10.1016\/j.clinthera.2008.05.005_bib18_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jacc.2005.04.050","article-title":"Ambrisentan therapy for pulmonary arterial hypertension","volume":"46","author":"Gali\u00e8","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2008.05.005_bib20","doi-asserted-by":"crossref","first-page":"256S","DOI":"10.1378\/chest.130.4_MeetingAbstracts.256S-b","article-title":"Ambrisentan has no clinically relevant effect on the pharmacokinetics or pharmacodynamics of warfarin","volume":"130","author":"Gerber","year":"2006","journal-title":"Chest"},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2008.05.005_bib21","doi-asserted-by":"crossref","first-page":"254S","DOI":"10.1378\/chest.130.4_MeetingAbstracts.254S-c","article-title":"No clinically relevant pharmacokinetic interaction between ambrisentan and sildenafil","volume":"130","author":"Dufton","year":"2006","journal-title":"Chest."},{"issue":"Suppl 4","key":"10.1016\/j.clinthera.2008.05.005_bib22","doi-asserted-by":"crossref","first-page":"121S","DOI":"10.1378\/chest.130.4_MeetingAbstracts.121S-a","article-title":"ARIES-1: A placebo controlled, efficacy and safety study of ambrisentan in patients with pulmonary arterial hypertension","volume":"130","author":"Oudiz","year":"2006","journal-title":"Chest"},{"unstructured":"Olschewski H, Gali\u00e8 N, Kramer M, Rubin LJ, for the ARIES-2 Study Group. Ambrisentan improves exercise capacity and time to clinical worsening in patients with pulmonary arterial hypertension: Results of the ARIES-2 Study. Abstract C85.","key":"10.1016\/j.clinthera.2008.05.005_bib23_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib24","first-page":"11","article-title":"A review of pulmonary arterial hypertension: Role of ambrisentan","volume":"3","author":"Barst","year":"2007","journal-title":"Vasc Health Risk Manage"},{"key":"10.1016\/j.clinthera.2008.05.005_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D'Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"unstructured":"Center for Drug Evaluation and Research. Application number 22-081. Medical review.","key":"10.1016\/j.clinthera.2008.05.005_bib26_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib27","doi-asserted-by":"crossref","first-page":"474a","DOI":"10.1378\/chest.132.4_MeetingAbstracts.474a","article-title":"Long-term ambrisentan therapy provides sustained benefit in patients with pulmonary arterial hypertension","volume":"132","author":"Oudiz","year":"2007","journal-title":"Chest"},{"unstructured":"McGoon M, Frost A, Rubin L, for the Ambrisentan in PAH Study Group. Ambrisentan therapy in patients with pulmonary arterial hypertension who discontinued bosentan or sitaxsentan due to liver function abnormalities: 1 Year follow-up. Abstract B15.","key":"10.1016\/j.clinthera.2008.05.005_bib28_1"},{"doi-asserted-by":"crossref","unstructured":"Letairis (ambrisentan). Caremark Specialty Pharmacy Services TrendsRx Alert. June 2007.","key":"10.1016\/j.clinthera.2008.05.005_bib29_1","DOI":"10.3833\/pdr.v2007i89.259"},{"key":"10.1016\/j.clinthera.2008.05.005_bib30","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1345\/aph.1C256","article-title":"Bosentan for the treatment of pulmonary arterial hypertension","volume":"37","author":"Kenyon","year":"2003","journal-title":"Ann Pharmacother"},{"unstructured":"Anderson SL, Heberlig RM, Koons K. The pharmacologic management of primary pulmonary hypertension. May 2003.","key":"10.1016\/j.clinthera.2008.05.005_bib31_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4037\/ccn1999.19.4.20","article-title":"Epoprostenol therapy for primary pulmonary hypertension","volume":"19","author":"Cheever","year":"1999","journal-title":"Crit Care Nurse"},{"unstructured":"Pulmonary Hypertension Association. Iloprost (Ventavis) fact sheet.","key":"10.1016\/j.clinthera.2008.05.005_bib33_1"},{"unstructured":"Letairis (ambrisentan) 5 mg and 10 mg tablets. How to get Letairis.","key":"10.1016\/j.clinthera.2008.05.005_bib34_1"},{"key":"10.1016\/j.clinthera.2008.05.005_bib35","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0895-7061(02)02933-3","article-title":"Darusentan: An effective endotheline A receptor antagonist for treatment of hypertension","volume":"15","author":"Nakov","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.clinthera.2008.05.005_bib36","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.crd.0000137737.54951.aa","article-title":"Tezosentan in the management of decompensated heart failure","volume":"13","author":"Cheng","year":"2005","journal-title":"Cardiol Rev"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808001756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:11:17Z","timestamp":1738260677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808001756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0149291808001756"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.05.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}